Financials

  • Market Capitalization 350.28 M
  • Employee 14
  • Founded 2005
  • CEO N/A
  • Website www.palisadebio.com
  • Headquarter Delaware, United States
  • FIGI BBG000QG4DJ2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
3.22
Price to sales ratio
883.58

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3120
IPSC
Century Therapeutics, Inc. - Common Stock
2.12 USD+2.42%+8.72%-0.93%+285.45%383.88 M USD
3151
LYEL
Lyell Immunopharma, Inc. - Common Stock
14.71 USD-5.28%+8.56%+15.19%-39.19%360.47 M USD
3192
DMAC
DiaMedica Therapeutics Inc. - Common Stock
6.51 USD-0.15%-1.66%-4.12%+8.14%351.06 M USD
3194
IKT
Inhibikase Therapeutics, Inc. - Common Stock
2.50 USD+4.60%+4.60%+5.93%+34.41%348.84 M USD

Frequently asked questions about Palisade Bio, Inc. Common Stock

What is the Palisade Bio, Inc. Common Stock stock price today?

The current price of Palisade Bio, Inc. Common Stock (PALI) is 2.01. Over the past 24 hours, the stock has changed by -4.29%. Follow the PALI chart for real-time price dynamics.

What is the stock ticker of Palisade Bio, Inc. Common Stock?

Palisade Bio, Inc. Common Stock trades under the ticker PALI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Palisade Bio, Inc. Common Stock stock going up?

PALI has changed by -6.51% over the last week, +2.55% over the last month, and +18.24% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Palisade Bio, Inc. Common Stock?

Palisade Bio, Inc. Common Stock currently has a market capitalization of 350.28 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Palisade Bio, Inc. Common Stock earnings last quarter?

Last quarter, Palisade Bio, Inc. Common Stock reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Palisade Bio, Inc. Common Stock revenue for the last quarter?

Palisade Bio, Inc. Common Stock reported quarterly revenue of 500 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Palisade Bio, Inc. Common Stock net income for the last quarter?

Palisade Bio, Inc. Common Stock reported net income of -10.57 M for the last quarter. The previous quarter showed -9.6 M, which means net income changed by -10.15%.

How many employees does Palisade Bio, Inc. Common Stock have?

As of the latest available data, Palisade Bio, Inc. Common Stock has 14 employees. Workforce size can provide additional context about the company's scale and operations.

What is Palisade Bio, Inc. Common Stock EBITDA?

Palisade Bio, Inc. Common Stock EBITDA is -11.7 M, and its EBITDA margin is -2 339.6%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Palisade Bio, Inc. Common Stock stock?

You can buy Palisade Bio, Inc. Common Stock (PALI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Palisade Bio, Inc. Common Stock stock?

Investing in Palisade Bio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PALI chart and related analysis on metatrader.com as part of your research.

News